Current Assets
Accounts Receivable
Medtronic Accounts Receivable decreased by 0.5% to $6.36B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 4.0%, from $6.12B to $6.36B. Over 4 years (FY 2021 to FY 2025), Accounts Receivable shows an upward trend with a 4.5% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
CategoryEfficiency
SignalLower is better
VolatilityStable
First reportedQ4 2015
Last reportedQ3 2026Feb 24, 2026
How to read this metric
A decrease relative to revenue suggests efficient collection processes, while an increase may signal potential credit issues or extended payment terms.
Detailed definition
This represents the total amount owed to the company by customers for products delivered or services rendered, adjusted...
Peer comparison
Medical device manufacturers typically have longer collection cycles due to complex hospital procurement processes.
Metric ID:
accounts_receivable_netHistorical Data
20 periods
| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $5.46B | $5.43B | $5.49B | $5.45B | $5.55B | $5.31B | $5.63B | $5.89B | $6B | $5.81B | $5.93B | $5.97B | $6.13B | $6.01B | $6.26B | $6.12B | $6.52B | $6.26B | $6.39B | $6.36B |
| QoQ Change | — | -0.6% | +1.1% | -0.9% | +1.9% | -4.4% | +6.0% | +4.6% | +1.9% | -3.2% | +2.2% | +0.6% | +2.7% | -1.9% | +4.1% | -2.3% | +6.5% | -3.9% | +2.0% | -0.5% |
| YoY Change | — | — | — | — | +1.6% | -2.3% | +2.4% | +8.1% | +8.1% | +9.4% | +5.5% | +1.4% | +2.2% | +3.5% | +5.5% | +2.5% | +6.3% | +4.2% | +2.1% | +4.0% |
Range$5.31B – $6.52B
CAGR+3.3%
Avg YoY Growth+4.0%
Median YoY Growth+3.8%
Accounts Receivable at Other Companies
Frequently Asked Questions
- What is Medtronic's accounts receivable?
- Medtronic (MDT) reported accounts receivable of $6.36B in Q4 2025.
- How has Medtronic's accounts receivable changed year-over-year?
- Medtronic's accounts receivable increased by 4.0% year-over-year, from $6.12B to $6.36B.
- What is the long-term trend for Medtronic's accounts receivable?
- Over 4 years (2021 to 2025), Medtronic's accounts receivable has grown at a 4.5% compound annual growth rate (CAGR), from $5.46B to $6.52B.
- What does accounts receivable mean?
- The net amount of money owed to the company by customers for goods or services already provided.